TOKENPOST
1 min read
Add as a preferred source on Google

Humacyte Plans November Dialysis Application, Projects Fourth-Quarter Symvess Sales

The filing would be a supplemental biologics license application, or sBLA.

By John Kim
Published
Clear tubing rests beside a dialysis machine in a quiet treatment bay / TokenPost.ai
Clear tubing rests beside a dialysis machine in a quiet treatment bay / TokenPost.ai

Humacyte projects Symvess sales for the fourth quarter. The company also plans to submit a supplemental biologics license application (sBLA) for dialysis in November.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…